183 related articles for article (PubMed ID: 17481556)
21. Overexpression of 15-Hydroxyprostaglandin Dehydrogenase Inhibits A549 Lung Adenocarcinoma Cell Growth via Inducing Cell Cycle Arrest and Inhibiting Epithelial-Mesenchymal Transition.
Wang W; Yang C; Deng H
Cancer Manag Res; 2021; 13():8887-8900. PubMed ID: 34876851
[TBL] [Abstract][Full Text] [Related]
22. 15-Hydroxyprostaglandin dehydrogenase (15-PGDH) is up-regulated by flurbiprofen and other non-steroidal anti-inflammatory drugs in human colon cancer HT29 cells.
Chi X; Freeman BM; Tong M; Zhao Y; Tai HH
Arch Biochem Biophys; 2009 Jul; 487(2):139-45. PubMed ID: 19501039
[TBL] [Abstract][Full Text] [Related]
23. 15-Hydroxyprostaglandin dehydrogenase is a tumor suppressor of human gastric cancer.
Liu Z; Wang X; Lu Y; Du R; Luo G; Wang J; Zhai H; Zhang F; Wen Q; Wu K; Fan D
Cancer Biol Ther; 2010 Oct; 10(8):780-7. PubMed ID: 20699658
[TBL] [Abstract][Full Text] [Related]
24. 15-Deoxy-Δ12,14-prostaglandin J2 induces expression of 15-hydroxyprostaglandin dehydrogenase through Elk-1 activation in human breast cancer MDA-MB-231 cells.
Kim HR; Lee HN; Lim K; Surh YJ; Na HK
Mutat Res; 2014 Oct; 768():6-15. PubMed ID: 25773924
[TBL] [Abstract][Full Text] [Related]
25. 15-Hydroxyprostaglandin-dehydrogenase is involved in anti-proliferative effect of non-steroidal anti-inflammatory drugs COX-1 inhibitors on a human medullary thyroid carcinoma cell line.
Quidville V; Segond N; Lausson S; Frenkian M; Cohen R; Jullienne A
Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):14-30. PubMed ID: 16997128
[TBL] [Abstract][Full Text] [Related]
26. 15-Hydroxyprostaglandin dehydrogenase is a target of hepatocyte nuclear factor 3beta and a tumor suppressor in lung cancer.
Huang G; Eisenberg R; Yan M; Monti S; Lawrence E; Fu P; Walbroehl J; Löwenberg E; Golub T; Merchan J; Tenen DG; Markowitz SD; Halmos B
Cancer Res; 2008 Jul; 68(13):5040-8. PubMed ID: 18593902
[TBL] [Abstract][Full Text] [Related]
27. Combined histone deacetylase and cyclooxygenase inhibition achieves enhanced antiangiogenic effects in lung cancer cells.
Wang X; Li G; Wang A; Zhang Z; Merchan JR; Halmos B
Mol Carcinog; 2013 Mar; 52(3):218-28. PubMed ID: 22121107
[TBL] [Abstract][Full Text] [Related]
28. ROS-Mediated 15-Hydroxyprostaglandin Dehydrogenase Degradation via Cysteine Oxidation Promotes NAD
Wang W; Hu Y; Wang X; Wang Q; Deng H
Cell Chem Biol; 2018 Mar; 25(3):255-261.e4. PubMed ID: 29307841
[TBL] [Abstract][Full Text] [Related]
29. Suppression of invasive properties of colorectal carcinoma SW480 cells by 15-hydroxyprostaglandin dehydrogenase gene.
Li M; Xie J; Cheng L; Chang B; Wang Y; Lan X; Zhang D; Yin Y; Cheng N
Cancer Invest; 2008 Nov; 26(9):905-12. PubMed ID: 19034772
[TBL] [Abstract][Full Text] [Related]
30. Expression of 15-PGDH is downregulated by COX-2 in gastric cancer.
Liu Z; Wang X; Lu Y; Han S; Zhang F; Zhai H; Lei T; Liang J; Wang J; Wu K; Fan D
Carcinogenesis; 2008 Jun; 29(6):1219-27. PubMed ID: 18174234
[TBL] [Abstract][Full Text] [Related]
31. 15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers.
Yan M; Rerko RM; Platzer P; Dawson D; Willis J; Tong M; Lawrence E; Lutterbaugh J; Lu S; Willson JK; Luo G; Hensold J; Tai HH; Wilson K; Markowitz SD
Proc Natl Acad Sci U S A; 2004 Dec; 101(50):17468-73. PubMed ID: 15574495
[TBL] [Abstract][Full Text] [Related]
32. Altered expression of 15-hydroxyprostaglandin dehydrogenase in tumor-infiltrated CD11b myeloid cells: a mechanism for immune evasion in cancer.
Eruslanov E; Kaliberov S; Daurkin I; Kaliberova L; Buchsbaum D; Vieweg J; Kusmartsev S
J Immunol; 2009 Jun; 182(12):7548-57. PubMed ID: 19494278
[TBL] [Abstract][Full Text] [Related]
33. A potential anti-tumor effect of leukotriene C4 through the induction of 15-hydroxyprostaglandin dehydrogenase expression in colon cancer cells.
Mehdawi LM; Satapathy SR; Gustafsson A; Lundholm K; Alvarado-Kristensson M; Sjölander A
Oncotarget; 2017 May; 8(21):35033-35047. PubMed ID: 28402256
[TBL] [Abstract][Full Text] [Related]
34. Regional differences in prostaglandin E₂ metabolism in human colorectal cancer liver metastases.
Young AL; Chalmers CR; Hawcroft G; Perry SL; Treanor D; Toogood GJ; Jones PF; Hull MA
BMC Cancer; 2013 Feb; 13():92. PubMed ID: 23442768
[TBL] [Abstract][Full Text] [Related]
35. Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-alpha.
Otani T; Yamaguchi K; Scherl E; Du B; Tai HH; Greifer M; Petrovic L; Daikoku T; Dey SK; Subbaramaiah K; Dannenberg AJ
Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G361-8. PubMed ID: 16195422
[TBL] [Abstract][Full Text] [Related]
36. UV radiation inhibits 15-hydroxyprostaglandin dehydrogenase levels in human skin: evidence of transcriptional suppression.
Judson BL; Miyaki A; Kekatpure VD; Du B; Gilleaudeau P; Sullivan-Whalen M; Mohebati A; Nair S; Boyle JO; Granstein RD; Subbaramaiah K; Krueger JG; Dannenberg AJ
Cancer Prev Res (Phila); 2010 Sep; 3(9):1104-11. PubMed ID: 20643784
[TBL] [Abstract][Full Text] [Related]
37. Role of glutamine 148 of human 15-hydroxyprostaglandin dehydrogenase in catalytic oxidation of prostaglandin E2.
Cho H; Huang L; Hamza A; Gao D; Zhan CG; Tai HH
Bioorg Med Chem; 2006 Oct; 14(19):6486-91. PubMed ID: 16828555
[TBL] [Abstract][Full Text] [Related]
38. Local modulation by 11beta-hydroxysteroid dehydrogenase of glucocorticoid effects on the activity of 15-hydroxyprostaglandin dehydrogenase in human chorion and placental trophoblast cells.
Patel FA; Sun K; Challis JR
J Clin Endocrinol Metab; 1999 Feb; 84(2):395-400. PubMed ID: 10022390
[TBL] [Abstract][Full Text] [Related]
39. 15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis.
Myung SJ; Rerko RM; Yan M; Platzer P; Guda K; Dotson A; Lawrence E; Dannenberg AJ; Lovgren AK; Luo G; Pretlow TP; Newman RA; Willis J; Dawson D; Markowitz SD
Proc Natl Acad Sci U S A; 2006 Aug; 103(32):12098-102. PubMed ID: 16880406
[TBL] [Abstract][Full Text] [Related]
40. Repression of 15-hydroxyprostaglandin dehydrogenase involves histone deacetylase 2 and snail in colorectal cancer.
Backlund MG; Mann JR; Holla VR; Shi Q; Daikoku T; Dey SK; DuBois RN
Cancer Res; 2008 Nov; 68(22):9331-7. PubMed ID: 19010907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]